Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jul 22;29(1):316.
doi: 10.1186/s13054-025-05575-5.

Sub-phenotypes in patients with out-of-hospital cardiac arrest who undergo extracorporeal cardiopulmonary resuscitation: a retrospective observational study from a multicenter registry

Affiliations
Observational Study

Sub-phenotypes in patients with out-of-hospital cardiac arrest who undergo extracorporeal cardiopulmonary resuscitation: a retrospective observational study from a multicenter registry

Masahiro Kashiura et al. Crit Care. .

Abstract

Background: Out-of-hospital cardiac arrest (OHCA) has poor survival rates, but extracorporeal cardiopulmonary resuscitation (ECPR) shows promise for selected patients, as a second line of therapy after failure of conventional CPR to obtain return of spontaneous circulation, despite implementation challenges. This study aimed to identify distinct sub-phenotypes among patients with OHCA who undergo ECPR and to investigate their association with clinical outcomes.

Methods: This multi-center, retrospective, observational study used the Japanese Association for Acute Medicine OHCA registry from 83 hospitals that performed ECPR among 91 participating centers between June 2014 and December 2020. We included adult patients with OHCA who received ECPR during cardiac arrest. Three-class latent class analysis (LCA) was employed to identify sub-phenotypes based on 15 variables, including pre- and in-hospital factors. Logistic regression analysis was used to assess the association between sub-phenotypes and 30-day survival and neurological outcomes.

Results: A total of 1528 patients were included. The median low-flow time was 47 min (interquartile rage: 38-58 min). The 30-day survival rate for eligible patients was 20.9%. LCA identified three distinct sub-phenotypes: Standard ECPR Group (n = 702), Delayed ECPR Group (n = 457), and Non-shockable Rhythm Group (n = 369). The variables with high discriminative power in the LCA was low-flow time, followed by pre-hospital shock delivery and initial cardiac rhythm. Thirty-day survival rates varied significantly among the sub-phenotypes (p = 0.001): Standard ECPR Group (26.9%), Delayed ECPR Group (17.1%), and Non-shockable Rhythm Group (14.1%). Favorable neurological outcomes at 30 days also differed significantly (p = 0.004), with the Standard ECPR Group showing the highest rate (12.1%). After adjusting for covariates, both the Delayed ECPR Group (adjusted OR: 0.61, 95% CI 0.44-0.82) and Non-shockable Rhythm Group (adjusted OR: 0.47, 95% CI 0.32-0.68) had significantly lower odds of 30-day survival compared to the Standard ECPR Group.

Conclusions: Three clinically meaningful sub-phenotypes were identified using simple pre-hospital and in-hospital factors, with low-flow time emerging as the most critical discriminating factor. The sub-phenotypes showed significant associations with clinical outcomes and provide a practical framework for ECPR patient stratification. These findings suggest that timing optimization may be as important as rhythm characteristics for ECPR patient selection and support the development of sub-phenotype-specific treatment strategies.

Keywords: Cardiac arrest; Extracorporeal cardiopulmonary resuscitation; Latent class analysis; Sub-phenotype.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The registry protocol was approved by the Institutional Review Board of each participating hospital. The participating hospitals are listed on the JAAM-OHCA website [28]. The requirement for informed consent was waived because the observational study design minimized risk to patients and preserved anonymity. Patients and their respective families were allowed to opt-out of the registry. The institutional research ethics committee of Jichi Medical University Saitama Medical Center approved the present study (S19-016). Consent for publication: Not applicable. No individual patient data will be reported. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of study participants and the number of participants in each sub-phenotype. CMO: extracorporeal membrane oxygenation; ECPR: extracorporeal cardiopulmonary resuscitation; LCA: latent class analysis; OHCA: out-of-hospital cardiac arrest; ROSC: return of spontaneous circulation
Fig. 2
Fig. 2
Discriminative power of each variable in descending order. CPR: cardiopulmonary resuscitation; ECMO: extracorporeal membrane oxygenation

Similar articles

References

    1. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639. - PubMed
    1. Yan S, Gan Y, Jiang N, Wang R, Chen Y, Luo Z, Zong Q, Chen S, Lv C. The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care. 2020;24(1):61. - PMC - PubMed
    1. Holmberg MJ, Granfeldt A, Guerguerian AM, Sandroni C, Hsu CH, Gardner RM, Lind PC, Eggertsen MA, Johannsen CM, Andersen LW. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: an updated systematic review. Resuscitation. 2023;182: 109665. - PubMed
    1. Low CJW, Ramanathan K, Ling RR, Ho MJC, Chen Y, Lorusso R, MacLaren G, Shekar K, Brodie D. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis. Lancet Respir Med. 2023;11(10):883–93. - PubMed
    1. Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, Collins G, Zhang L, Kalra R, Kosmopoulos M, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807–16. - PMC - PubMed

Publication types

MeSH terms